Key terms

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CUE news

Apr 11 11:20am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 09 9:35am ET Cue Biopharma: A Strong Buy on Clinical Breakthroughs and Strategic Financial Positioning by TipRanks Apr 09 7:35am ET Oppenheimer Remains a Buy on Cue Biopharma (CUE) by TipRanks Apr 09 7:07am ET Cue Biopharma (CUE) Gets a Buy from Stifel Nicolaus by TipRanks Apr 09 7:06am ET Cue Biopharma (CUE) Gets a Buy from Piper Sandler by TipRanks Apr 08 7:05am ET Options Volatility and Implied Earnings Moves Today, April 08, 2024 by TipRanks Apr 08 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 08 – April 12, 2024 by TipRanks Apr 03 7:06am ET Piper Sandler Remains a Buy on Cue Biopharma (CUE) by TipRanks Mar 13 5:01am ET Analysts’ Top Healthcare Picks: Cooper Co (COO), Regeneron (REGN) by TipRanks Mar 13 4:58am ET Cue Biopharma initiated with a Buy at Jefferies by TipRanks Feb 29 10:04am ET Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium by TipRanks Feb 26 8:10am ET Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE) by TipRanks Feb 20 7:45am ET Cue Biopharma (CUE) Gets a Buy from Piper Sandler by TipRanks

No recent press releases are available for CUE

CUE Financials

1-year income & revenue

Key terms

CUE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CUE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments